Neok, an AP-HP spin-off, is revolutionizing oncology prevention by leveraging the latest scientific advancements. Its multi-cancer check-up aims to detect developing cancers at early stages (I/II), thereby maximizing treatment effectiveness and increasing survival rates.
Founded in 2024 by four Parisian oncologists who share a common ambition: to make advancements in cancer prevention and detection accessible to everyone.
Neok has designed an innovative check-up that can detect cancers at their earliest stages.
A three-step approach:
1. Risk Questionnaire: A free initial assessment based on 110 clinical biomarkers, allowing for the establishment of a personalized risk profile.
2. In-depth Biological Analysis: A home blood test to measure over 50 biological biomarkers, complementing the initial assessment.
3. Medical Report and Support: The Neok medical team provides a detailed analysis, and in case of concerning signals, directs the patient to an appropriate specialist.
Why join the 21st by CentraleSupélec accelerator?
• Leverage a cutting-edge research ecosystem to enhance our artificial intelligence and refine our predictive models.
• Access a talent pool to strengthen the technological development of our platform and accelerate the national and international deployment of the Neok check-up.
https://neok.fr/
#service #earlydetection #multicancer #AI #Biomarkers
.avif)
